Physician profile
Jeffrey Sinclair
NPI 1558329540
$3,896.74
in general payments reported to CMS, 2019-2025
12 companies · $820 in 2025
The $820 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $513 · 2021: $582 · 2022: $663 · 2023: $656 · 2024: $458 · 2025: $820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,934.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,934.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,897.54 | 2019-2025 | Dailies Total1, Precision7, Hydrus Microstent |
| Johnson & Johnson Vision Care, INC. | $514.25 | 2019-2025 | Acuvue |
| Coopervision INC. | $271.42 | 2019-2023 | Myday Contact Lens |
| Amgen INC. | $267.03 | 2024-2025 | Tepezza |
| Bausch & Lomb Americas INC. | $246.93 | 2024-2025 | Xiidra, Miebo |
| Horizon Therapeutics Plc | $165.54 | 2023 | Tepezza |
| Johnson & Johnson Surgical Vision, INC. | $135.19 | 2025 | Tecnis Iol |
| Maculogix, INC. | $131.20 | 2020 | |
| Harrow Eye, LLC | $125.00 | 2025 | Vevye |
| Samsara Vision | $63.91 | 2022 | |
| Abb Con-Cise Optical Group LLC | $53.98 | 2019-2024 | Contact Lens, Spectacle Lenses |
| Sun Pharmaceutical Industries INC. | $24.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Sinclair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.